[CGTX] YoY Quarter Result on 31-Dec-2023 [#Q4]

Stock
[CGTX] Cognition Therapeutics, Inc.
Announcement Date
26-Mar-2024
Financial Year
2023
Quarter
31-Dec-2023 [#Q4]
Profit Trend
QoQ- -20.63%
YoY- -174.20%
Quarter Report
CGTX's Result
CGTX's Financial Summary
View:
Show?
Quarter Result
31/12/23 31/12/22 31/12/21 31/12/20 CAGR
Revenue 372 0 0 0 -
PBT -8,141 -5,182 -7,339 -1,868 63.34%
Tax 2,297 -16,154 387 658 51.69%
NP -8,141 10,972 -7,339 -1,868 63.34%
Tax Rate - - - - -
Total Cost 8,513 -10,972 7,339 1,868 65.79%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 CAGR
NP Margin -2,188.44 0.00 0.00 0.00 -
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 CAGR
EPS -0.26 0.38 -0.35 -0.09 42.42%
EPS Diluted -0.26 0.38 -0.35 -0.09 42.42%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.